Description
The Precision Nanosystems NanoAssemblr Ignite enables the controlled and precise formulation of lipid nanoparticles (LNPs) using NxGen mixing technology, making it a key tool for preclinical genomic medicine development. The Ignite maintains the same process parameters as the NanoAssemblr Blaze and GMP System, which simplifies the transition into clinical development and manufacturing, allowing for seamless formulation scaling. Incorporating critical process steps for scale-up early in preclinical development, even at low volumes, reduces risks, simplifies workflows, and accelerates drug development timelines.
With a maximum volume of 20 mL and a flow rate of up to 20 mL/min, the NanoAssemblr Ignite system uses NxGen Microfluidic Mixing Technology to ensures precise and rapid nanoparticle assembly. It minimises batch-to-batch and user variability, provides precise control over fluidic flow rates and ratios, and allows for fine-tuning of critical quality attributes (CQAs) such as particle size. These features make it an essential tool for the efficient and scalable development of genomic medicines.
Key Features of the Precision Nanosystems NanoAssemblr Ignite:
- Maximum Volume 20 mL
- Maximum Flow Rate 20 mL/min
- NxGen Microfluidic Mixing Technology
- Scalable Formulations Across NanoAssemblr Platform
- Minimises Batch-to-Batch and User Variability
- Precise Control Over Fluidic Flow Rates & Ratios
- Fine Tune Critical Quality Attributes (CQAs) e.g. Particle Size
- Model: NIN0001
Brochure for the NanoAssemblr Ignite
Manual for the NanoAssemblr Ignite
*Precision Nanosystems is now Cytiva
